Detalhe da pesquisa
1.
Consensus criteria for diagnosis, staging, and treatment response assessment of T-cell prolymphocytic leukemia.
Blood
; 134(14): 1132-1143, 2019 10 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31292114
2.
The assessment of platelet function by thromboelastometry as a point-of-care test to guide Intercept-treated platelet support in hemato-oncological patients and hematopoietic stem cell transplantation recipients.
Transfusion
; 60(7): 1391-1399, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32319678
3.
First-in-human response of BCL-2 inhibitor venetoclax in T-cell prolymphocytic leukemia.
Blood
; 130(23): 2499-2503, 2017 12 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-28972014
4.
Torquetenovirus Dynamics and Immune Marker Properties in Patients Following Allogeneic Hematopoietic Stem Cell Transplantation: A Prospective Longitudinal Study.
Biol Blood Marrow Transplant
; 24(1): 194-199, 2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29032273
5.
Extracorporeal photopheresis as second-line therapy for patients with acute graft-versus-host disease: does the number of cells treated matter?
Transfusion
; 58(4): 1045-1053, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29446444
6.
Influence of body mass index on survival in indolent and mantle cell lymphomas: analysis of the StiL NHL1 trial.
Ann Hematol
; 96(7): 1155-1162, 2017 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-28456850
7.
Development of a comprehensive prognostic index for patients with chronic lymphocytic leukemia.
Blood
; 124(1): 49-62, 2014 Jul 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-24797299
8.
Rationale for the combination of venetoclax and ibrutinib in T-prolymphocytic leukemia.
Haematologica
; 106(8): 2251-2256, 2021 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33626863
9.
A modified scoring of the NCCN-IPI is more accurate in the elderly and is improved by albumin and ß2 -microglobulin.
Br J Haematol
; 168(2): 239-45, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25236324
10.
Interactions between comorbidity and treatment of chronic lymphocytic leukemia: results of German Chronic Lymphocytic Leukemia Study Group trials.
Haematologica
; 99(6): 1095-100, 2014 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-24584349
11.
Lenalidomide in combination with vorinostat and dexamethasone for the treatment of relapsed/refractory peripheral T cell lymphoma (PTCL): report of a phase I/II trial.
Ann Hematol
; 93(3): 459-62, 2014 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-24441915
12.
Sequential chemoimmunotherapy of fludarabine, mitoxantrone, and cyclophosphamide induction followed by alemtuzumab consolidation is effective in T-cell prolymphocytic leukemia.
Cancer
; 119(12): 2258-67, 2013 Jun 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-23512246
13.
Limited clinical relevance of imaging techniques in the follow-up of patients with advanced chronic lymphocytic leukemia: results of a meta-analysis.
Blood
; 117(6): 1817-21, 2011 Feb 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-21139079
14.
Mixed-phenotype acute leukemia: clinical and laboratory features and outcome in 100 patients defined according to the WHO 2008 classification.
Blood
; 117(11): 3163-71, 2011 Mar 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-21228332
15.
Rituximab serum concentrations during immuno-chemotherapy of follicular lymphoma correlate with patient gender, bone marrow infiltration and clinical response.
Haematologica
; 97(9): 1431-8, 2012 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-22511498
16.
The frequency of differentiated CD3+CD27-CD28- T cells predicts response to CART cell therapy in diffuse large B-cell lymphoma.
Front Immunol
; 13: 1004703, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36700229
17.
Functional Precision Medicine Provides Clinical Benefit in Advanced Aggressive Hematologic Cancers and Identifies Exceptional Responders.
Cancer Discov
; 12(2): 372-387, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34635570
18.
Successful alemtuzumab retreatment in progressive B-cell chronic lymphocytic leukemia: a multicenter survey in 30 patients.
Ann Hematol
; 90(9): 1083-91, 2011 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-21350830
19.
A patient diagnosed with BRAF-mutated non-small cell lung cancer and hairy cell leukemia: at last, which entity is really carrying the BRAF mutation?
Ann Hematol
; 94(2): 345-6, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25055797
20.
Anti-Apoptotic Molecule BCL2 Is a Therapeutic Target in Steroid-Refractory Graft-Versus-Host Disease.
J Invest Dermatol
; 140(11): 2188-2198, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32247860